Ahọpụtara nyocha ahụike na ọrụ mmepe Hengsheng n'ime katalọgụ nke ngwaahịa dijitalụ (ọrụ) maka mgbochi ọrịa na-adịghị ala ala na ọgwụgwọ nke Centre for Control and Prevention nke China.

Na Jenụwarị 2023, dị ka Centerlọ Ọrụ Na-ahụ Maka Nchịkwa na Mgbochi Ọrịa nke China kwupụtara, ahọpụtara ọrụ nyocha na mmepe nke Hengsheng Medical Technology Co., Ltd. (“Hengsheng Medical”) “Smart Chronic Disease Management Platform”, n'ime ihe ngosi Katalọgụ nke Ngwaahịa Dijitalụ (ọrụ) maka mgbochi na ọgwụgwọ ọrịa na-adịghị ala ala (2022)”.

Arịrịọ na nhọrọ nke ngwaahịa na ọrụ dijitalụ ahụkarị maka mgbochi na ọgwụgwọ nke ọrịa na-adịghị ala ala nọ n'okpuru nduzi na nkwado nke Ngalaba Atụmatụ na Ozi nke National Health Commission of the People's Republic of China na Department of Electronic Information of Ministry of Industry. na Ozi teknụzụ.Nke China Center for Disease Control and Chronic Diseases na China Academy of Information and Communication Technology na-akwado.

Hangzhou Hengsheng Medical Technology Co., Ltd nwere ngwaahịa usoro "PRO Dọkịta" nke ya.Ka ọ dị ugbu a, ngwaahịa ụlọ ọrụ na-agụnye mgbapụta insulin, nyocha glucose ọbara na-aga n'ihu, usoro nchọpụta glucose ọbara, sistemu uric acid nchọpụta, usoro nchọpụta cholesterol, nha ọbara mgbali elu, nchọpụta ọrịa na-efe efe, ịzụ anụmanụ na ule anụ ụlọ, yana reagents na ngwa ndị metụtara ya.

The ụlọ ọrụ nwere ụwa na-eduga mmepụta ngwá na elu-edu R&D, mmepụta na management otu, jikwaa ngwaahịa àgwà ike dị ka ISO13485 àgwà management usoro, na rụrụ ụlọ ọrụ-mahadum-nyocha imekọ ihe ọnụ na Zhejiang University, Shanghai Jiaotong University. na mahadum ndị ọzọ.Ka ọ dị ugbu a, a ghọtara ụlọ ọrụ ahụ dị ka ụlọ ọrụ nkà na ụzụ dị elu na China.

Ime ka onye ọ bụla nwee ahụ dị mma na ndụ ka mma na ịchụso izu okè, ịdị mma, nraranye na mmeri na ngalaba ahụike, Hengsheng dị njikere n'ezie ka ya na ndị nwere nghọta na-arụkọ ọrụ na ụlọ na esenidụt iji mepụta ọdịnihu dị mma.